Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma.
Kaori
K
Sakaizawa
Atsuko
A
Ashida
Hisashi
H
Uhara
Ryuhei
R
Okuyama
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000097:blood* / Q000134:cerebrospinal fluid; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000556:secondary; D008207:Lymphatic Metastasis; D008297:Male; D008545:Melanoma / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D010996:Pleural Effusion / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D016133:Polymerase Chain Reaction; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics* / Q000378:metabolism; D013449:Sulfonamides / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D000077484:Vemurafenib
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf